Valenciennes Hospital Centre   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Valenciennes France (2000)

Organization Overview

First Clinical Trial
2014
NCT02176681
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Central Hospital, Valenciennes | Centre Hospitalier VALENCIENNES | CH de Valenciennes | Hospital of Valenciennes | Valenciennes Hospital, Valenciennes, FRANCE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteritis (Phase 3)

Chondrocalcinosis (Phase 4)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Giant Cell Arteritis (Phase 3)

Polymyalgia Rheumatica (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8